tirzepatide and anesthesia GLP-1 Medication Disclosure Before Anesthesia: Essential Pre-Surgery Guide One-Week GLP-1 Agonist Hold Not – Having a procedure with us

International Congress of Hematology, 1988

Semaglutide, as a pure GLP-1 agonist, causes GI side effects primarily through delayed gastric emptying

Beyond glycemic effects, GLP-1 receptor agonists slow gastric emptying, which prolongs the sensation of fullness after meals and contributes to reduced caloric intake

Thus, GLP-1 analogs are prepared considering two key points in mind: (i) Native GLP-1 is cleaved by DPP-4 at Ala8, and (ii) Arg or Lys residues are susceptible to serine protease cleavage, more specifically Lys34

Natural GLP-1 support supplements typically produce a gentler, more gradual shift in appetite patterns that some users notice clearly while others barely perceive

To put that in perspective, the approved GLP-1 drugs achieved less weight loss in longer timeframes: for example, semaglutide (Wegovy) averages about 15% weight loss over ~16 months, and tirzepatide (Zepbound) achieved around 22.5% at 72 weeks in trials